Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NVC-422
NVC-422
NVC-422 Gives NovaBay Huge Growth Potential
Seeking Alpha
Mon, 12/9/13 - 11:20 am
NVC-422
NovaBay Pharmaceuticals
adenoviral conjunctivitis
Novabay: A Novel Agent Against A Common Problem
Seeking Alpha
Wed, 02/20/13 - 11:55 am
NovaBay Pharmaceuticals
NVC-422
antibiotics
NovaBay's Sugar Daddy, Galderma, Pushes Impetigo Treatment
Seeking Alpha
Mon, 02/18/13 - 12:04 pm
Galderma
impetigo
NovaBay Pharmaceuticals
NVC-422
South Africa
NovaBay: Potential Of NVC-422 For Treating Impetigo Is Key Factor In Recent Long Recommendation
Seeking Alpha
Mon, 11/5/12 - 11:32 am
NovaBay
NVC-422
impetigo
Galderma and NovaBay Enroll First Patients in Phase 2b Clinical Study of NVC-422 for Impetigo
Yahoo
Mon, 09/24/12 - 10:23 am
Galderma
NovaBay
NVC-422
impetigo
NovaBay Ocular Trial Taps Broad Activity Of Its Anti-Infective
Seeking Alpha
Wed, 05/30/12 - 10:28 am
NovaBay
NVC-422
adenoviral conjunctivitis
NovaBay's Game-Changing Technology May Be Attracting Attention
Seeking Alpha
Wed, 12/14/11 - 10:58 am
NovaBay Pharmaceuticals
Aganocide
NVC-422
anti-infectives